Experience

Charles Centro Oftalmológico

• Argentina
• Medical Practices
• 1 - 100 Employee

• Sub investigador

  • Jun 2021 - Present

  Sub investigadora en Protocolo XTEND. Bayer. (Evaluation of an eXtended and proacTive Dosing regimEn in Treatment-Naïve Patients With Wet Age-related Macular Degeneration) Estudio observacional prospectivo de FASE 4.

• Sub Investigador

  • Apr 2021 - Present

  Sub investigadora en ensayo clínico de GATHER 2, Iveric Bio (A Phase 3 Multicenter, Randomized, Double Masked, Sham- Controlled Clinical Trial to Assess the Safety and Efficacy of Intravitreal Administration of Zimura (Complement C5 Inhibitor) in Patients With Geographic Atrophy Secondary to Age-Related Macular Degeneration) Ensayo clínicorandomizado, doble enmascarado, multicentrico de FASE III.

• Sub Investigador

  • Jun 2021 - Present

  Sub investigadora en ensayo clínico PULSAR, Bayer. (Efficacy and Safety of High Dose Aflibercept in Patients With Neovascular Age-Related Macular Degeneration) Ensayo clínico, randomizado, doble enmascarado de FASE III.

• Sub Investigador

  • Oct 2021 - Present

  Sub investigadora en LUCERNE, Hoffmann-La Roche. (A Study to Evaluate the Efficacy and Safety of Faricimab in Participants With Neovascular Age-Related Macular Degeneration) Estudio multicentrico, randomizado, doble enmascarado FASE III.

• Sub Investigador

  • Nov 2021 - Present

  Sub investigadora en ensayo clínico BALATON, Hoffmann-La Roche. (A Study to Evaluate the Efficacy and Safety of Faricimab in Participants With Macular Edema Secondary to Branch Retinal Vein Occlusion) Estudio multicentrico, doble enmascarado FASE III.

• Sub Investigador

  • Nov 2021 - Present

  Sub investigadora en ensayo clínico COMINO, Hoffmann-La Roche (A Study to Evaluate the Efficacy and Safety of Faricimab in Participants With Macular Edema Secondary to Central Retinal or Hemiretinal Vein Occlusion) Estudio multicentrico, randomizado, doble enmascarado de FASE III.

• Sub Investigador

  • Nov 2021 - Present

  Sub investigadora en AVONELLE-X, Hoffmann-La Roche (A Study to Evaluate the Efficacy and Safety of Faricimab in Participants With Neovascular Age-Related Macular Degeneration). FASE III.

• Sub Investigador

  • Nov 2021 - Present

  Sub investigadora en COAST, Ofthea Limited OPT-302 With Aflibercept in Neovascular Age-related Macular Degeneration ( A Phase 3, Multicentre, Double-masked, Randomized Study to Evaluate the Efficacy and Safety of Intravitreal OPT-302 in Combination With Aflibercept, Compared With Aflibercept Alone, in Participants With nAMD)

• Sub Investigador

  • Jan 2022 - Present

  Sub investigadora en GALE, Apellis Pharmaceuticals, Inc. An Extension Study to Evaluate the Long-term Safety and Efficacy of Pegcetacoplan (APL-2) in Subjects With Geographic Atrophy Secondary to AMD (A Phase 3, Open-Label, Multicenter, Extension Study to Evaluate the Long-Term Safety and Efficacy of Pegcetacoplan in Subjects With Geographic Atrophy Secondary to Age-Related Macular Degeneration)

• Oftalmologa. Retina Medica.

  • May 2020 - Present

• Oftalmóloga. Fellowship Retina Médica

  • Oct 2020 - Jun 2022



Hospital Oftalmologico Pedro Lagleyze

• Ciudad de Buenos Aires, Provincia de Buenos Aires, Argentina

• Residente de oftalmología

  • Jun 2016 - Sep 2020